Schedule 13G ownership disclosure

BriaCell Therapeutics Corp.

Common Shares, no par value · CUSIP: 107930208

Event date: 2025-07-15

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • CVI Investments, Inc.

    Shares: 1,000,000 · Class: 5.7%

  • Heights Capital Management, Inc.

    Shares: 1,000,000 · Class: 5.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001649553-25-000130
Form type
SCHEDULE 13G
Filer
BriaCell Therapeutics Corp.
CIK
CIK 1610820
Filed
Jul 22, 2025
Reporting period
Jul 15, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub